The American Pain Society (APS) will present a 3-hour REMS CME activity, along with a full-day track on chronic pain assessment and treatment at the PAINWeek 2013 National Conference.
Montclair, NJ (PRWEB) July 24, 2013
PAINWeek, the National Conference on Pain for Frontline Practitioners, today announced that the American Pain Society (APS) will again contribute its expertise to the 2013 conference agenda, with the presentation of two all-new educational programs.
On Thursday, September 5, APS will present a 3-hour educational activity that complies with the FDA’s Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting (ER/LA) Opioids. APS is a member of the Collaborative for REMS Education (CO*RE), and PAINWeek is excited to partner with them to provide this program to frontline practitioners. This activity is intended to increase the knowledge of prescribers of ER/LA opioids so that they can more confidently and effectively manage patients on these medications. The program will provide general and product-specific drug information for this class of medications. Specific topics to be covered include: assessing patients for treatment with ER/LA opioid analgesics; how to initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics; managing ongoing therapy with ER/LA opioid analgesics; and counseling patients and caregivers about the safe use, storage, and disposal of ER/LA opioid analgesics. REMS course faculty includes: Charles Argoff, MD, CPE, of Albany Medical College; Katherine Galluzzi, DO, of the Philadelphia College of Osteopathic Medicine; Sandra Keavey, MPAS, DFAAPA, representing the American Academy of Physician Assistants; and Barbara St. Marie, PhD, ANP-BC, GNP-BC, ACHPN, of the University of Minnesota Medical Center.
On Friday, September 6, PAINWeek will present the APS track entitled “New Developments in Evidence-Based Pain Assessment and Treatment”, which includes 4 sessions presented by APS faculty who are leaders in the pain field. The goal of this track is to inform attendees of the most recent evidence regarding pain assessment and treatment and how they can use this information in their own setting. The first session, led by APS President Roger Fillingim, PhD, will discuss the use of quantitative sensory testing (QST) as a method for identifying the mechanisms that may be driving patients’ pain. The second session, by Stanford University’s Sean Mackey, MD, PhD, CPE, will discuss the use of brain imaging as a potential objective biomarker of pain. Dr. Mackey is a leader in the rapidly growing brain imaging field, and has recently undertaken exciting new research in this arena. The third session, presented by Michael Smith, PhD, CBSM, from Johns Hopkins, will discuss how to assess and manage sleep problems in patients with pain. Sleep disturbance is among the most common comorbidities in patients with pain, and normalizing sleep can have tremendous benefits for pain control. Finally, Kathleen Sluka, PT, PhD, from the University of Iowa, will discuss the evidence regarding exercise and pain. Dr. Sluka has done pioneering work in both preclinical and clinical studies of exercise and pain, and is noted for her expertise in communicating the science in a digestible, practical, and useful way.
Commenting on the planned proceedings, Dr. Fillingim said, “I am delighted that the American Pain Society is participating in PAINWeek for the second year in a row. APS sees this as an excellent opportunity to provide evidence-based pain education at the country’s largest meeting for frontline practitioners.“
Debra Weiner, Director of Program Development for PAINWeek added, “We welcome our continued collaboration with the American Pain Society, and its distinguished presenters, most of whom are also veteran PAINWeek faculty. The APS programs will provide an abundance of valuable information regarding pain assessment and treatment, and we look forward to sharing this with our conference participants.”
PAINWeek is the largest US pain conference for frontline practitioners with an interest in pain management. Convening for its 7th year on September 4-7, 2013, in Las Vegas, PAINWeek expects to welcome over 1800 physicians, nurses, pharmacists, and other healthcare professionals for a comprehensive program of course offerings, satellite events, and exhibits. Over 100 hours of continuing medical education activities will be presented. To learn more about the conference, opportunities for participation, and to register for PAINWeek 2013, visit http://www.painweek.org.